Literature DB >> 16204003

Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance.

Marlene H Frost1, Jeffrey M Slezak, Nho V Tran, Constance I Williams, Joanne L Johnson, John E Woods, Paul M Petty, John H Donohue, Clive S Grant, Jeff A Sloan, Thomas A Sellers, Lynn C Hartmann.   

Abstract

PURPOSE: Contralateral prophylactic mastectomy (CPM) is one option for reducing the risk of a second breast cancer in women with a personal and family history of breast cancer. Few data are available regarding satisfaction, psychological, and social function after CPM. The purpose of this research is to evaluate women's long-term satisfaction with CPM, factors influencing satisfaction, and psychological and social function after CPM. PATIENTS AND METHODS: This was a descriptive study of all women with a family history of breast cancer, known to be alive, who elected CPM at Mayo Clinic (Rochester, MN) between 1960 and 1993 (n = 621). Ninety-four percent of the women (n = 583) completed a study-specific questionnaire.
RESULTS: A mean of 10.3 years after the procedure, the majority of women (83%) were satisfied with their CPM. A smaller number were neutral (8%) or dissatisfied (9%). Women who had a subcutaneous mastectomy had more problems with reconstruction, and fewer of these women were satisfied than women with simple mastectomy. Decreased satisfaction with CPM was associated with decreased satisfaction with appearance, complications with reconstruction, reconstruction after CPM, and increased level of stress in life. The majority of women experienced no change or favorable effects in self-esteem (83%), level of stress in life (83%), and emotional stability (88%). Satisfaction with body appearance, feelings of femininity, and sexual relationships were the most adversely affected with 33%, 26%, and 23% of the women responding negatively.
CONCLUSION: Although most women are satisfied with CPM, each woman should weigh the benefits alongside the potential adverse effects.

Entities:  

Mesh:

Year:  2005        PMID: 16204003     DOI: 10.1200/JCO.2005.09.233

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  52 in total

1.  Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.

Authors:  Jada G Hamilton; Margaux C Genoff; Melissa Salerno; Kimberly Amoroso; Sherry R Boyar; Margaret Sheehan; Megan Harlan Fleischut; Beth Siegel; Angela G Arnold; Erin E Salo-Mullen; Jennifer L Hay; Kenneth Offit; Mark E Robson
Journal:  Breast Cancer Res Treat       Date:  2017-02-01       Impact factor: 4.872

Review 2.  Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis.

Authors:  Oluwadamilola Motunaryo Fayanju; Carolyn R T Stoll; Susan Fowler; Graham A Colditz; Julie A Margenthaler
Journal:  Ann Surg       Date:  2014-12       Impact factor: 12.969

Review 3.  Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients.

Authors:  Giacomo Montagna; Monica Morrow
Journal:  Expert Rev Anticancer Ther       Date:  2020-02-28       Impact factor: 4.512

4.  Met and Unmet Expectations for Breast Reconstruction in Early Posttreatment Breast Cancer Survivors.

Authors:  Laurie E Steffen; Aimee Johnson; Beverly J Levine; Deborah K Mayer; Nancy E Avis
Journal:  Plast Surg Nurs       Date:  2017 Oct/Dec

Review 5.  Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.

Authors:  Tuya Pal; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2012-10       Impact factor: 3.302

Review 6.  Management updates for women with a BRCA1 or BRCA2 mutation.

Authors:  Rachel Nusbaum; Claudine Isaacs
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

7.  Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.

Authors:  Shoshana M Rosenberg; Michaela S Tracy; Meghan E Meyer; Karen Sepucha; Shari Gelber; Judi Hirshfield-Bartek; Susan Troyan; Monica Morrow; Lidia Schapira; Steven E Come; Eric P Winer; Ann H Partridge
Journal:  Ann Intern Med       Date:  2013-09-17       Impact factor: 25.391

8.  Women's perceptions of the personal and family impact of genetic cancer risk assessment: focus group findings.

Authors:  Deborah J MacDonald; Linda Sarna; Jeffrey N Weitzel; Betty Ferrell
Journal:  J Genet Couns       Date:  2009-11-10       Impact factor: 2.537

9.  Cost of contralateral prophylactic mastectomy.

Authors:  Ashish A Deshmukh; Scott B Cantor; Melissa A Crosby; Wenli Dong; Yu Shen; Isabelle Bedrosian; Susan K Peterson; Patricia A Parker; Abenaa M Brewster
Journal:  Ann Surg Oncol       Date:  2014-05-09       Impact factor: 5.344

10.  Mastectomies on the rise for breast cancer: "the tide is changing".

Authors:  Charles M Balch; Lisa K Jacobs
Journal:  Ann Surg Oncol       Date:  2009-07-31       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.